The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemosensitivity and clinical characteristics of pancreatic malignancies in BRCA mutation carriers.
Talia Golan
No relevant relationships to disclose
Zaheer Kanji
No relevant relationships to disclose
Ron Epelbaum
No relevant relationships to disclose
Nicholas Devaud
No relevant relationships to disclose
Efrat Dagan
No relevant relationships to disclose
Spring Holter
No relevant relationships to disclose
Dan Aderka
No relevant relationships to disclose
Bella Kaufman
No relevant relationships to disclose
Ruth Gershoni-Baruch
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Eitan Friedman
No relevant relationships to disclose
Steven Gallinger
No relevant relationships to disclose